Immutep Ltd. (IMMP)
3.86
-0.20
(-4.93%)
USD |
NASDAQ |
Oct 08, 14:41
Immutep Market Cap : 28.44M for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 29.92M |
| October 06, 2026 | 31.98M |
| October 05, 2026 | 31.46M |
| October 02, 2026 | 32.05M |
| October 01, 2026 | 33.45M |
| September 30, 2026 | 34.26M |
| September 29, 2026 | 34.71M |
| September 28, 2026 | 35.96M |
| September 25, 2026 | 38.83M |
| September 24, 2026 | 38.61M |
| September 23, 2026 | 39.22M |
| September 22, 2026 | 834.42M |
| September 21, 2026 | 858.59M |
| September 18, 2026 | 847.98M |
| September 17, 2026 | 934.04M |
| September 16, 2026 | 963.81M |
| September 15, 2026 | 973.54M |
| September 14, 2026 | 975.90M |
| September 11, 2026 | 1.100B |
| September 10, 2026 | 958.21M |
| September 09, 2026 | 1.047B |
| September 08, 2026 | 1.075B |
| September 04, 2026 | 1.076B |
| September 03, 2026 | 1.076B |
| September 02, 2026 | 1.129B |
| Date | Value |
|---|---|
| September 01, 2026 | 1.094B |
| August 31, 2026 | 1.079B |
| August 28, 2026 | 1.123B |
| August 27, 2026 | 1.122B |
| August 26, 2026 | 1.120B |
| August 25, 2026 | 1.126B |
| August 24, 2026 | 1.138B |
| August 21, 2026 | 1.138B |
| August 20, 2026 | 1.153B |
| August 19, 2026 | 1.159B |
| August 18, 2026 | 1.171B |
| August 17, 2026 | 1.139B |
| August 14, 2026 | 1.120B |
| August 13, 2026 | 1.189B |
| August 12, 2026 | 1.129B |
| August 11, 2026 | 1.159B |
| August 10, 2026 | 1.132B |
| August 07, 2026 | 1.137B |
| August 06, 2026 | 1.106B |
| August 05, 2026 | 1.156B |
| August 04, 2026 | 1.160B |
| August 03, 2026 | 1.121B |
| July 31, 2026 | 1.126B |
| July 30, 2026 | 1.119B |
| July 29, 2026 | 1.122B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CSL Ltd. | 60.36B |
| Ceryvyn Therapeutics Ltd. | 4.446M |
| Propanc Biopharma, Inc. | 1.535M |
| Mesoblast Ltd. | 1.774B |
| Actinogen Medical Ltd. | 198.16M |
Market Cap Related Metrics
| PS Ratio | 2.832 |
| PEG Ratio | -0.0093 |
| Price | 3.86 |
| Earnings Yield | -188.6% |
| PEGY Ratio | -0.0093 |